Scientific Program

Organizers: W. Ray Kim , Bülent Değertekin, Zeki Karasu, Ramazan Idilman

TIME	HALL 1
08:30-08:40	Introduction W. Ray Kim/Bülent Değertekin
	Session 1 - Abstract Presentations Moderators: Osman Özdoğan, Hale Gökcan, Arif Mansur Coşar
08:40-10:10	Young investigator presentations
10:10-10:30	Coffee Break
	Session 2 - Steatotic liver disease 1: MASLD Moderators: Halis Şimşek, Ramazan İdilman, Yusuf Yılmaz
10:30-10:50	TLM Debrief: MASLD Meena B. Bansal
10:50-11:10	Screening of MASLD - Evidence-based Approach W. Ray Kim
11:10-11:30	Care of MASLD Müjdat Zeybel
11:30-12:15	Case-based panel discussion (2 Case presenters) and Q&A Zeynep Melekoğlu Ellik, Filiz Araz
12:15-13:05	Session 3 – BAYER Satellite Symposium: Current Perspectives in HCC: Prevalence and Imaging Innovations Moderator: Ramazan İdilman
	The prevalence of HCC Ramazan Idilman
	One Step Further in HCC Imaging: The Contribution of Hepatocyte-Specific Contrast Agents Muşturay Karçaanltıncaba
13:05-14:00	Lunch Break
	Session 4 - Debate #1 Primary endpoint of MASH Treatment: MASH resolution or Fibrosis improvement Judges: Meena B. Bansal and Cynthia Levy
14:00-14:30	Dilara Turan Gökçe- Burcu Gürbüz Vs Şencan Acar- Berkay Dertsiz
	Session 5 - Chronic Liver Disease Moderators: Cemal Nuri Erçin, Savaş Cumali Efe, Aslı Örmeci
14:30-14:50	TLM Debrief: Autoimmune and Cholestatic Liver Disease Cynthia Levy
14:50-15:10	Non-invasive assessment of cirrhosis and portal hypertension İlker Turan
15:10-15:30	TLM Debrief: Portal hypertension Cynthia Levy
15:30-16:15	Case-based panel discussion (2 Case presenters) and Q&A Bilger Çavuş, A. Mübin Özercan
16:15-16:40	Coffee Break
	Session 6 - Special Session: Practice Guidelines Moderators: Meral Akdoğan Kayhan, Yasemin Balaban, Gupse Adalı
16:40-17:10	AASLD Guidelines 2025-2026 Cynthia Levy
17:10-17:20	Q&A
17:20-17:30	Closing W. Ray Kim/Bülent Değertekin

TIME	HALL 1
08:30-08:35	Opening
	Session 7 - Steatotic liver disease 2: ALD Moderators: Nurdan Tözün, Yılmaz Çakaloğlu, Dinç Dinçer
08:35-08:55	TLM debrief: ALD Jessica L. Mellinger
08:55-09:15	Met-ALD as a distinct clinical entity: diagnosis and management Meena B. Bansal
09:15-09:35	Hepatologist's guide to alcohol use disorder Jessica L. Mellinger
09:35-10:20	Case-based panel discussion (2 Case presenters) and Q&A Nilay Danış, Zekiye Nur Harput
10:20-10:45	Coffee Break
	Session 8 - HCC Moderators: Levent Doğanay, Deniz Balcı, Bora Peyniricoğlu
10:45-11:05	TLM Debrief: HCC Pierre Gholam
11:05-11:25	Multidisciplinary model of care in liver cancer Coşkun Demirtaş
11:25-11:45	Update: Cholangiocarcinoma Pierre Gholam
11:45-12:30	Case-based multidisipliniary panel discussion (2 Case presenters) and Q&A Genco Gençdal, Özge Koç
12:30-13:30	Lunch Break
13:30-14:00	Session 9 - Debate #2 Cholestatic liver disease: what is the treatment target? Biochemical response or clinical improvement Judges: Pierre Gholam and Jessica L. Mellinger
	İlkay Ergenç- Hasan Eruzun Vs Kenan Moral- Zülal İstemihan
	Session 10 - Liver transplantation Moderators: Zeki Karasu, Sezai Yılmaz, Gökhan Kabaçam
14:00-14:20	TLM update: Liver transplantation Pierre Gholam
14:20-14:40	Controversies in Early LT for AH Jessica L. Mellinger
14:40-15:00	Recent Lessons in Liver Allocation in the US W. Ray Kim
15:00-15:45	Case-based panel discussion (2 Case presenters) and Q&A Murat Harputluoğlu, Elvan Işık
15:45-16:00	Coffee Break
	Session 11 - Viral Hepatitis Moderators: Ulus S. Akarca, Sabahattin Kaymakoğlu, Mehmet Koruk
16:00-16:20	TLM Debrief: Viral hepatitis W. Ray Kim
16:20-16:40	Hepatitis B Guidelines AASLD, EASL, WHO: What works in Turkiye Suna Yapalı
16:40-17:00	TASL-AASLD Community Conversations on HDV Bülent Değertekin
17:00-17:45	Case-based panel discussion (2 Case presenters) and Q&A Onur Keskin, Kübra Köken
17:45-17:50	Closing

IMPORTANT DATES

6 February

Congress Start Date

7 February

Congress End Date

3 January

Abstract Last
Submission Date